285 related articles for article (PubMed ID: 20591221)
1. Polymorphic catechol-O-methyltransferase gene, soy isoflavone intake and breast cancer in postmenopausal women: a case-control study.
Wang Q; Wang YP; Li JY; Yuan P; Yang F; Li H
Chin J Cancer; 2010 Jul; 29(7):683-8. PubMed ID: 20591221
[TBL] [Abstract][Full Text] [Related]
2. Soy isoflavones, CYP1A1, CYP1B1, and COMT polymorphisms, and breast cancer: a case-control study in southwestern China.
Wang Q; Li H; Tao P; Wang YP; Yuan P; Yang CX; Li JY; Yang F; Lee H; Huang Y
DNA Cell Biol; 2011 Aug; 30(8):585-95. PubMed ID: 21438753
[TBL] [Abstract][Full Text] [Related]
3. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer.
Lavigne JA; Helzlsouer KJ; Huang HY; Strickland PT; Bell DA; Selmin O; Watson MA; Hoffman S; Comstock GW; Yager JD
Cancer Res; 1997 Dec; 57(24):5493-7. PubMed ID: 9407957
[TBL] [Abstract][Full Text] [Related]
4. Polymorphic catechol-O-methyltransferase gene and breast cancer risk.
Mitrunen K; Jourenkova N; Kataja V; Eskelinen M; Kosma VM; Benhamou S; Kang D; Vainio H; Uusitupa M; Hirvonen A
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):635-40. PubMed ID: 11401913
[TBL] [Abstract][Full Text] [Related]
5. Limited association between a catechol-O-methyltransferase (COMT) polymorphism and breast cancer risk in Japan.
Hamajima N; Matsuo K; Tajima K; Mizutani M; Iwata H; Iwase T; Miura S; Oya H; Obata Y
Int J Clin Oncol; 2001 Feb; 6(1):13-8. PubMed ID: 11706521
[TBL] [Abstract][Full Text] [Related]
6. Catechol-O-methyltransferase gene polymorphism and post-menopausal breast cancer risk.
Wedrén S; Rudqvist TR; Granath F; Weiderpass E; Ingelman-Sundberg M; Persson I; Magnusson C
Carcinogenesis; 2003 Apr; 24(4):681-7. PubMed ID: 12727796
[TBL] [Abstract][Full Text] [Related]
7. Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancer.
Yim DS; Parkb SK; Yoo KY; Yoon KS; Chung HH; Kang HL; Ahn SH; Noh DY; Choe KJ; Jang IJ; Shin SG; Strickland PT; Hirvonen A; Kang D
Pharmacogenetics; 2001 Jun; 11(4):279-86. PubMed ID: 11434504
[TBL] [Abstract][Full Text] [Related]
8. Polymorphic catechol-O-methyltransferase gene, duration of estrogen exposure, and breast cancer risk: a nested case-control study in Taiwan.
Lin WY; Chou YC; Wu MH; Jeng YL; Huang HB; You SL; Chu TY; Chen CJ; Sun CA
Cancer Detect Prev; 2005; 29(5):427-32. PubMed ID: 16191465
[TBL] [Abstract][Full Text] [Related]
9. [Prevalence of Val158Met polymorphism in COMT gene on non-BRCA1/2 hereditary breast cancer].
Song CG; Hu Z; Yuan WT; Di GH; Shen ZZ; Huang W; Shao ZM
Zhonghua Wai Ke Za Zhi; 2006 Oct; 44(19):1310-3. PubMed ID: 17217814
[TBL] [Abstract][Full Text] [Related]
10. Genetic susceptibility of catechol-O-methyltransferase polymorphism in Japanese patients with breast cancer.
Inoue H; Shibuta K; Matsuyama A; Yoshinaga K; Sadanaga N; Ueo H; Barnard GF; Mori M
Oncol Rep; 2005 Sep; 14(3):707-12. PubMed ID: 16077979
[TBL] [Abstract][Full Text] [Related]
11. Catechol-O-methyltransferase Val 108/158 Met polymorphism in premenopausal breast cancer patients.
Sazci A; Ergul E; Utkan NZ; Canturk NZ; Kaya G
Toxicology; 2004 Nov; 204(2-3):197-202. PubMed ID: 15388245
[TBL] [Abstract][Full Text] [Related]
12. Combined effects of MDM2 SNP309 and TP53 R72P polymorphisms, and soy isoflavones on breast cancer risk among Chinese women in Singapore.
Koh WP; Van Den Berg D; Jin A; Wang R; Yuan JM; Yu MC
Breast Cancer Res Treat; 2011 Dec; 130(3):1011-9. PubMed ID: 21833626
[TBL] [Abstract][Full Text] [Related]
13. Val158Met Polymorphism in catechol-O-methyltransferase gene associated with risk factors for breast cancer.
Hong CC; Thompson HJ; Jiang C; Hammond GL; Tritchler D; Yaffe M; Boyd NF
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):838-47. PubMed ID: 14504192
[TBL] [Abstract][Full Text] [Related]
14. [Polymorphism of catechol-O-methyltransferase gene in relation to the risk of endometrial cancer].
Zhao XM; Xie MQ; Yang DZ; Wang LA; Li SJ; Zhuang YY; Tang XL
Zhonghua Fu Chan Ke Za Zhi; 2007 Feb; 42(2):116-9. PubMed ID: 17442187
[TBL] [Abstract][Full Text] [Related]
15. A multigenic study on breast cancer risk associated with genetic polymorphisms of ER Alpha, COMT and CYP19 gene in BRCA1/BRCA2 negative Shanghai women with early onset breast cancer or affected relatives.
Hu Z; Song CG; Lu JS; Luo JM; Shen ZZ; Huang W; Shao ZM
J Cancer Res Clin Oncol; 2007 Dec; 133(12):969-78. PubMed ID: 17562079
[TBL] [Abstract][Full Text] [Related]
16. Association of COMT Val158Met polymorphism and breast cancer risk: an updated meta-analysis.
Qin X; Peng Q; Qin A; Chen Z; Lin L; Deng Y; Xie L; Xu J; Li H; Li T; Li S; Zhao J
Diagn Pathol; 2012 Oct; 7():136. PubMed ID: 23039364
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.
Huang CS; Chern HD; Chang KJ; Cheng CW; Hsu SM; Shen CY
Cancer Res; 1999 Oct; 59(19):4870-5. PubMed ID: 10519398
[TBL] [Abstract][Full Text] [Related]
18. Combined effect of GSTM1, GSTT1, and COMT genotypes in individual breast cancer risk.
Park SK; Yim DS; Yoon KS; Choi IM; Choi JY; Yoo KY; Noh DY; Choe KJ; Ahn SH; Hirvonen A; Kang D
Breast Cancer Res Treat; 2004 Nov; 88(1):55-62. PubMed ID: 15538046
[TBL] [Abstract][Full Text] [Related]
19. Influence of the catechol-O-methyltransferase (COMT) codon 158 polymorphism on estrogen levels in women.
Worda C; Sator MO; Schneeberger C; Jantschev T; Ferlitsch K; Huber JC
Hum Reprod; 2003 Feb; 18(2):262-6. PubMed ID: 12571159
[TBL] [Abstract][Full Text] [Related]
20. Catechol-O-methyltransferase and breast cancer risk.
Millikan RC; Pittman GS; Tse CK; Duell E; Newman B; Savitz D; Moorman PG; Boissy RJ; Bell DA
Carcinogenesis; 1998 Nov; 19(11):1943-7. PubMed ID: 9855007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
